Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Receives Average Recommendation of “Moderate Buy” from Brokerages

Shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) have earned a consensus recommendation of “Moderate Buy” from the twelve brokerages that are presently covering the company, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $10.7778.

A number of equities analysts have recently weighed in on AVAH shares. Weiss Ratings reiterated a “hold (c+)” rating on shares of Aveanna Healthcare in a research note on Thursday, July 2nd. Stephens upgraded Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and boosted their price target for the company from $10.00 to $11.00 in a research note on Friday, May 15th. Truist Financial increased their price objective on Aveanna Healthcare from $9.00 to $11.00 and gave the stock a “hold” rating in a research report on Tuesday, July 14th. Barclays lifted their target price on Aveanna Healthcare from $9.00 to $9.50 and gave the stock an “overweight” rating in a report on Thursday, July 9th. Finally, Royal Bank Of Canada raised shares of Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 target price for the company in a research report on Wednesday, June 3rd.

Aveanna Healthcare Stock Performance

AVAH stock opened at $9.33 on Thursday. Aveanna Healthcare has a 1-year low of $3.74 and a 1-year high of $10.32. The business’s 50-day moving average price is $8.53 and its two-hundred day moving average price is $7.71. The firm has a market cap of $2.03 billion, a PE ratio of 7.91, a P/E/G ratio of 0.93 and a beta of 1.90. The company has a current ratio of 1.47, a quick ratio of 1.47 and a debt-to-equity ratio of 5.35.

Aveanna Healthcare (NASDAQ:AVAH) last issued its quarterly earnings data on Thursday, May 14th. The company reported $0.18 EPS for the quarter, topping analysts’ consensus estimates of $0.13 by $0.05. Aveanna Healthcare had a net margin of 10.37% and a return on equity of 124.68%. The business had revenue of $647.91 million for the quarter, compared to analyst estimates of $613.22 million. The firm’s revenue was up 15.9% on a year-over-year basis. As a group, research analysts forecast that Aveanna Healthcare will post 0.68 earnings per share for the current year.

Insiders Place Their Bets

In related news, major shareholder Paul R. Vigano sold 7,000,000 shares of the business’s stock in a transaction on Wednesday, June 3rd. The stock was sold at an average price of $6.24, for a total transaction of $43,680,000.00. Following the sale, the insider owned 252,899 shares in the company, valued at $1,578,089.76. The trade was a 96.51% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, major shareholder Robert M. Williams, Jr. sold 7,000,000 shares of the company’s stock in a transaction on Wednesday, June 3rd. The shares were sold at an average price of $6.24, for a total transaction of $43,680,000.00. Following the completion of the sale, the insider directly owned 252,899 shares in the company, valued at approximately $1,578,089.76. This represents a 96.51% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 31,305,664 shares of company stock worth $215,555,910 over the last 90 days. Corporate insiders own 5.30% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the company. Dynamic Technology Lab Private Ltd boosted its holdings in Aveanna Healthcare by 8.9% in the 3rd quarter. Dynamic Technology Lab Private Ltd now owns 14,149 shares of the company’s stock worth $126,000 after buying an additional 1,151 shares during the period. Barclays PLC boosted its stake in Aveanna Healthcare by 0.8% in the 3rd quarter. Barclays PLC now owns 179,359 shares of the company’s stock worth $1,591,000 after purchasing an additional 1,366 shares during the period. Franklin Resources Inc. increased its position in shares of Aveanna Healthcare by 4.5% during the third quarter. Franklin Resources Inc. now owns 35,630 shares of the company’s stock valued at $316,000 after buying an additional 1,528 shares during the period. Intech Investment Management LLC boosted its position in shares of Aveanna Healthcare by 9.8% in the fourth quarter. Intech Investment Management LLC now owns 19,483 shares of the company’s stock valued at $159,000 after acquiring an additional 1,739 shares during the period. Finally, Caitong International Asset Management Co. Ltd lifted its stake in Aveanna Healthcare by 252.4% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock worth $27,000 after purchasing an additional 2,400 shares in the last quarter. 87.96% of the stock is owned by institutional investors.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.